SCHEMBL13508192

SCHEMBL13508192

c1ccc2c(c1)Cc1ccccc1N2c1ccc2c(c1)oc1c3oc4cc(N5c6ccccc6Cc6ccccc65)ccc4c3c3ccccc3c21

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.36
PTGER4 P35408 1/20 0.33
DYRK1A Q13627 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13508054 0.92 ALDH1A1 (0.33) PTGER4DYRK1A
SCHEMBL13507253 0.89 HPGD (0.37) HPGDPTGER4
SCHEMBL13508085 0.82 PTGER4 (0.36) PTGER4DYRK1A
SCHEMBL13508051 0.81 HDAC6 (0.39) PTGER4DYRK1A
SCHEMBL13507702 0.80 ALDH1A1 (0.34) HPGDPTGER4
SCHEMBL19319676 0.80 MAOA (0.49) HPGDPTGER4
SCHEMBL13615784 0.79 HPGD (0.41) HPGD
SCHEMBL13615965 0.79 HPGD (0.41) HPGD
SCHEMBL13511479 0.79 ALDH1A1 (0.30)
SCHEMBL13507947 0.78 KDM4E (0.34) PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 HPGD 1044/4885PTGER4 2154/4885DYRK1A 4493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.